Anti-Glucose Transporter GLUT1抗体[SPM498] (ab40084)

ab40084 被引用在 52 文献中.

• Pizzuti L  et al. GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer. J Cell Physiol 233:1396-1401 (2018). PubMed: 28542798
• Sowa T  et al. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression. Cancer Med 6:288-297 (2017). PubMed: 28028936
• Kim JH  et al. Alpha lipoic acid attenuates radiation-induced oral mucositis in rats. Oncotarget 8:72739-72747 (2017). PubMed: 29069822
• Cavalcante IP  et al. High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. Acta Radiol 57:370-7 (2016). PubMed: 25766729
• Albert V  et al. mTORC2 sustains thermogenesis via Akt-induced glucose uptake and glycolysis in brown adipose tissue. EMBO Mol Med 8:232-46 (2016). WB ; Mouse . PubMed: 26772600
• Zhang L  et al. Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa. Hum Mol Genet N/A:N/A (2016). PubMed: 27516389
• Zhang L  et al. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. J Clin Invest 126:4659-4673 (2016). WB ; Mouse . PubMed: 27841758
• Prieto P  et al. Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells. Front Physiol 7:548 (2016). Human . PubMed: 27899899
• Henning Y & Szafranski K Age-Dependent Changes of Monocarboxylate Transporter 8 Availability in the Postnatal Murine Retina. Front Cell Neurosci 10:205 (2016). IHC-Fr ; Mouse . PubMed: 27616981
• Bourseau-Guilmain E  et al. Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. Nat Commun 7:11371 (2016). IHC-Fr . PubMed: 27094744
• Barquissau V  et al. White-to-brite conversion in human adipocytes promotes metabolic reprogramming towards fatty acid anabolic and catabolic pathways. Mol Metab 5:352-65 (2016). WB ; Human . PubMed: 27110487
• Palmer CS  et al. Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis. EBioMedicine 6:31-41 (2016). WB, Flow Cyt ; Human . PubMed: 27211546
• Dey J  et al. A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo. PLoS One 11:e0158617 (2016). IHC-P ; Mouse . PubMed: 27359113
• Schisler JC  et al. Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin. J Am Heart Assoc 4:N/A (2015). WB ; Mouse . PubMed: 25713290
• Tsuneki M  et al. A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway. Lab Invest 95:765-80 (2015). Mouse . PubMed: 25961170
• Miura S  et al. Fluid shear triggers microvilli formation via mechanosensitive activation of TRPV6. Nat Commun 6:8871 (2015). Electron Microscopy, ICC/IF ; Human . PubMed: 26563429
• Nogueira AB  et al. Existence of a potential neurogenic system in the adult human brain. J Transl Med 12:75 (2014). IHC-P ; Human . PubMed: 24655332
• Ramratnam M  et al. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J Am Heart Assoc 3:N/A (2014). PubMed: 25092788
• Eilertsen M  et al. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLoS One 9:e105038 (2014). IHC-P ; Human . PubMed: 25225794
• Chang S  et al. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations. Pathol Int 64:607-12 (2014). PubMed: 25376377
• Hegedus A  et al. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 11:98 (2014). Flow Cyt . PubMed: 25421745
• Vaughan RA  et al. ß-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer 13:14 (2014). Flow Cyt, ICC/IF ; Human . PubMed: 24460609
• Ganapathy S  et al. A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protection. J Biol Chem 289:5340-7 (2014). WB ; Human . PubMed: 24391088
• Bravo-Nuevo A  et al. Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. PLoS One 9:e90031 (2014). WB ; Mouse . PubMed: 24587200
• Freemerman AJ  et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 289:7884-96 (2014). WB ; Rat . PubMed: 24492615
• Kim S  et al. The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma. J Breast Cancer 16:146-51 (2013). IHC-P ; Human . PubMed: 23843845
• Longati P  et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13:95 (2013). WB ; Human . PubMed: 23446043
• Sorrentino NC  et al. A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. EMBO Mol Med 5:675-90 (2013). IHC-Fr ; Mouse . PubMed: 23568409
• Morato PN  et al. Whey protein hydrolysate increases translocation of GLUT-4 to the plasma membrane independent of insulin in wistar rats. PLoS One 8:e71134 (2013). WB . PubMed: 24023607
• Cioffi S  et al. Tbx1 regulates brain vascularization. Hum Mol Genet N/A:N/A (2013). PubMed: 23945394
• Pyla R  et al. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells. Am J Physiol Cell Physiol 304:C574-89 (2013). PubMed: 23302780
• Flavahan WA  et al. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat Neurosci 16:1373-82 (2013). Flow Cyt ; Human . PubMed: 23995067
• Ganeshan B  et al. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326-36 (2013). IHC-P ; Human . PubMed: 23169792
• Salani B  et al. Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II. Sci Rep 3:2070 (2013). WB, ICC/IF ; Human . PubMed: 23797762
• Choi J  et al. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res 15:R78 (2013). PubMed: 24020991
• Jang SM  et al. The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas. J Breast Cancer 15:172-80 (2012). IHC-P ; Human . PubMed: 22807934
• Kim JE  et al. Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab Anim Res 28:181-91 (2012). WB ; Rat . PubMed: 23091518
• Mandeville HC  et al. Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. Radiology 264:581-9 (2012). IHC-P ; Human . PubMed: 22700554
• Takadate T  et al. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues. Int J Cancer : (2012). IHC-P ; Human . PubMed: 22915188
• Smeland E  et al. Prognostic impacts of hypoxic markers in soft tissue sarcoma. Sarcoma 2012:541650 (2012). IHC-P ; Human . PubMed: 22454562
• Jun YJ  et al. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 17:1866-73 (2011). IHC-P ; Human . PubMed: 21528061
• Andersen S  et al. Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer 72:294-302 (2011). PubMed: 21075472
• Merlini M  et al. Vascular ß-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAß mice. Acta Neuropathol 122:293-311 (2011). IHC-FoFr ; Mouse . PubMed: 21688176
• Lee YK  et al. Differential regulation of the biosynthesis of glucose transporters by the PI3-K and MAPK pathways of insulin signaling by treatment with novel compounds from Liriope platyphylla. Int J Mol Med 27:319-27 (2011). WB ; Mouse . PubMed: 21165549
• Ruderisch N  et al. Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3. J Cereb Blood Flow Metab 31:1637-47 (2011). Mouse . PubMed: 21364602
• Mattmiller SA  et al. Glucose transporter and hypoxia-associated gene expression in the mammary gland of transition dairy cattle. J Dairy Sci 94:2912-22 (2011). PubMed: 21605761
• Koo JS & Kim H Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary. Tumour Biol 32:893-904 (2011). PubMed: 21598042
• Hasselbalch B  et al. Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. APMIS 118:585-94 (2010). IHC-P ; Human . PubMed: 20666740
• Banerjee SK  et al. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 49:683-92 (2010). WB ; Mouse . PubMed: 20600102
• Xiao C  et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 285:36776-84 (2010). WB, IHC-P ; Mouse . PubMed: 20847051
• Svensson KJ  et al. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase. Cancer Res 68:9291-301 (2008). IHC-P, IF ; Human . PubMed: 19010902
• Khan ZA  et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592-9 (2008). IHC-P ; Human . PubMed: 18535669